Premium
Maternal Mortality Associated with Eclampsia and Severe Preeclampsia of Pregnancy
Author(s) -
Sawhney H.,
Aggarwal N.,
Biswas R.,
Vasishta K.,
Gopalan S.
Publication year - 2000
Publication title -
journal of obstetrics and gynaecology research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.597
H-Index - 50
eISSN - 1447-0756
pISSN - 1341-8076
DOI - 10.1111/j.1447-0756.2000.tb01338.x
Subject(s) - medicine , eclampsia , preeclampsia , maternal death , pregnancy , obstetrics , coma (optics) , retrospective cohort study , population , genetics , physics , environmental health , optics , biology
Objective: To analyse factors associated with maternal mortality in eclampsia and preeclampsia. Method: Retrospective analysis of 69 maternal deaths due to (eclampsia‐61; severe preeclampsia‐8) was carried out during a period of 17 years (1982–1998). Maternal condition on admission, associated complications and principal cause of death was analysed in each case. Results: Mean time interval between hospitalization and maternal death was 49.56 + 62.01 hrs (1–240 hrs). Twenty (28.9%) women died undelivered. Twenty‐three (37.7%) women were in grade IV coma and 52.4% of eclampsia patients had recurrent convulsions (> 10) prior to admission. Associated complications in form of hemorrhage, cerebrovascular accidents, acute renal failure, jaundice, aspiration pneumonia and pulmonary oedema were 30.4, 31.8, 34.8, 18.8, 17.8, and 5.8%, respectively. Maternal mortality in eclampsia was significantly low in time period B (4.1%) when magnesium sulphate was used as an anticonvulsant. Conclusions: Maternal condition on admission and associated complications are the major determinant of maternal outcome. Use of magnesium sulphate is associated with significant reduction of maternal mortality.